Nachrichten zur Merck KGaA Aktie

Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent…

Merck Aktie: Sorgen um Krebsstudie überzogen? Wells Fargo sieht Kaufchance

San Francisco (www.aktiencheck.de) - Merck-Aktienanalyse von Wells Fargo Advisors:Die Analysten von Wells Fargo bestätigen ihr Rating "overweight" für die Aktie…

Moderna stock’s 17% slump was a ‘sell the news’ event, analyst says

Moderna shares tumbled after leaked cancer vaccine trial data showed promising results for its treatment developed with Merck.…

Pharma: Krebsimpfstoff-Daten von Moderna und Merck vorzeitig veröffentlicht – Aktien fallen

Vorzeitig bekannt gewordene Studiendaten zu einem Krebsimpfstoff setzen Moderna und Merck & Co. unter Druck. Zeitweise verlor die Moderna-Aktie bis…

Merck (MRK) Laps the Stock Market: Heres Why

The latest trading day saw Merck (MRK) settling at $149.88, representing a +1.07% change from its previous close.…

Merck Aktienanalyse: Übernahme für 1,3 Mrd. USD - Neue Chancen?

Bad Marienberg (www.aktiencheck.de) - Die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol: MRK, NASDAQ OTC-Symbol: MKGAF) rückt mit…

Merck (MRK) Stock Dips While Market Gains: Key Facts

In the closing of the recent trading day, Merck (MRK) stood at $143.63, denoting a -1.59% move from the preceding…

Merck Hold

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA angesichts der Übernahme von Silence Therapeutics…

Zukauf: Merck kauft britische Silence Therapeutics für Milliardensumme

Das im Dax gelistete Unternehmen übernimmt einen britischen Biotechkonzern. Damit soll das Geschäft für Medikamente gegen seltene Erkrankungen angekurbelt werden.…

Silence Therapeutics jumps 59% on Merck takeover

Silence Therapeutics PLC (NASDAQ:SLN, FRA:XRP1, OTC:SLNCF), the clinical-stage biotechnology company, surged 59% to $6.11 after agreeing to a $1.3...…

Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make

His comments come after Merck officially opened its new 120,000-square-foot research facility in the Greater Philadelphia area.…

Merck Aktie: Prognose-Anhebung durch Life Science - startet jetzt das Comeback?

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Jens Klatt, Marktanalyst bei XTB, nimmt die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990,…

Tempus AI Expands Strategic Collaborations to Drive Future Growth

TEM is expanding its precision medicine footprint through strategic collaborations with Moderna, Merck and Recursion, paving the way for future…

HALO Wins Court Order Blocking Mercks Keytruda SC in Europe

Halozyme wins a Dutch court order blocking Mercks Keytruda SC in eight European markets, strengthening its position in the patent…

Börse für Frühstarter: DAX-Prognose schwächer – Porsche, VW, Rheinmetall, Telekom und Merck im Fokus

Der deutsche Aktienmarkt hat gestern, am Dienstag, fester geschlossen: Der DAX gewann 0,8 Prozent auf 25.449 Punkte. Heute, am Mittwoch,…

Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity?

Mercks 7% dip may offer a buying opportunity as Keytruda drives growth and new products and pipeline assets strengthen its…

Why Merck (MRK) Dipped More Than Broader Market Today

In the latest trading session, Merck (MRK) closed at $145.31, marking a -2.66% move from the previous day.…

Merck Aktie: Wichtige Durchschnittslinien durchbrochen

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

Merck Inks $2.1B Deal With Chinese Biotech to Expand Oncology Pipeline

MRKs $2.13 billion deal for SPR2015 adds a preclinical KRAS G12D inhibitor to its precision oncology pipeline, targeting a common…

Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package

Bio-Techne Corporation (NASDAQ:TECH) shareholders voted on September 23 to approve the company’s acquisition by Merck KGaA of Darmstadt, Germany. The…

Mercks Remigromig Meets Main Goal in Diabetic Macular Edema Study

MRKs remigromig meets the primary goal in a DME study, showing non-inferiority to ranibizumab while further safety analyses continue.…

Bank of America has strong message for Merck stock investors

A private meeting with the drugmakers top doctor points to the next make-or-break moment for shareholders.…

Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

Oncology Tie-Up and Blockchain Pilot Might Change The Case For Investing In Merck (MRK)

In early September 2026, Merck & Co., Inc. deepened its innovation push through multiple investor conferences and a new clinical…

Jim Cramer Explains Why Merck (MRK) Is His Fantasy Defense Stock

Discussing his fantasy roster on the September 8 episode of Mad Money, Jim Cramer turned his focus to pharmaceutical giant…

Merck (MRK) Dips More Than Broader Market: What You Should Know

In the most recent trading session, Merck (MRK) closed at $144.71, indicating a -1.91% shift from the previous trading day.…

Top Stock Reports for Oracle, Merck & Union Pacific

Oracle, Merck and Union Pacific lead todays stock reports, with cloud growth, drug sales and rail strength driving their investment…

Merck Aktie mit 10% Kurspotenzial: Barclays erhöht Kursziel auf 150 Euro

Bad Marienberg (www.aktiencheck.de) - Analyst James Gordon hebt das Kursziel von 140 auf 150 Euro an. Das Rating "equal-weight" bleibt…

Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Merck (MRK) concluded the recent trading session at $150.32, signifying a -1.33% move from its prior days close.…

Why Is Merck (MRK) Up 18.2% Since Last Earnings Report?

Merck (MRK) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Merck Aktie: HSBC zündet Kaufsignal!

Bad Marienberg (www.aktiencheck.de) - Bei der Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol: MRK, NASDAQ OTC-Symbol: MKGAF) dreht…

AKTIE IM FOKUS: Merck KGaA lassen dank 'Buy' von HSBC Trendlinien hinter sich

FRANKFURT (dpa-AFX) - Eine Kaufempfehlung der Investmentbank HSBC hat den Aktien von Merck KGaA am…

Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets.

Johnson & Johnson and Merck are healthcare giants with dependable returns that weather economic downturns well.…

Why Did RUM, MRK, NEM Stocks Jump To 52-Week Highs Today?

Rum Group, Merck, and Newmont shares surged to annual highs amid positive company catalysts, Wall Street optimism, and a rise…

Myriad Genetics and Moderna Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after shares across biotech and big pharma cooled further as traders…

A cancer vaccine years in the making just proved itself

Merck added billions in a single day after its Moderna-partnered cancer vaccine cleared a major hurdle.…

Merck & Co. Aktienanalyse: Keytruda-Patentablauf verliert seinen Schrecken - BofA bleibt bei "buy"

Bad Marienberg (www.aktiencheck.de) - Die Aktie von Merck & Co. Inc. (ISIN: US58933Y1055, WKN: A0YD8Q, Ticker-Symbol: 6MK, NYSE-Symbol: MRK) rückt…

Moderna Aktie: William Blair vollzieht die Kehrtwende - Krebs-Durchbruch verändert die Story!

Bad Marienberg (www.aktiencheck.de) - Was für eine Woche für Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol: MRNA)! Erst…

Merck vs. J&J: Which Healthcare Giant Should Investors Choose?

JNJs diversified portfolio and pipeline strength offer an edge over MRK as both face patent expiration challenges.…

Can Mercks New Drugs Offer Growth Cushion Ahead of Keytruda LOE?

MRKs growing pipeline, acquired assets and new product launches are gaining traction as it builds a diversified growth base ahead…

Cancer vaccine breakthrough at Moderna raises hopes for Scancells melanoma programme

A landmark trial success for Moderna and Mercks cancer vaccine has strengthened the case for Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF,…

Merck is a buy as strong cancer drug pipeline offsets Keytruda patent expiration, Morgan Stanley says

Merck, which makes the popular cancer treatment Keytruda, is poised to gain ground as its pipeline drugs get close to…

ANALYSE-FLASH: UBS senkt Merck KGaA auf 'Neutral' - Ziel 150 Euro

ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat Merck KGaA beim unveränderten Kursziel von…

Merck KGaA shares fall after UBS downgrades stock to Neutral

Merck KGaA shares fall after UBS downgrades stock to Neutral…

Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.…

Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data

Today, Aug. 19, 2026, Modernas personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA…

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Merck and Modernas success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of…

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.…

Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Heres What That Means for Investors.

The treatment combines an mRNA shot with Mercks Keytruda.…

Merck, Moderna say melanoma skin cancer vaccine meets goals in large trial

Merck and Moderna said on Wednesday a study of a personalized mRNA vaccine combined with the immunotherapy drug Keytruda reduced…